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Abstract  
Infections of the skin and soft tissues (SSTI) are clinical entities with variable presentations, causes, and levels of 
clinical severity. They are frequent in emergency departments. The most common pathogen in the Western World 
is Staphylococcus aureus. SSTI may provide a hint to underlying pathologies such as diabetes and other states of 
immune compromise. Here we present a 41-year-old non-diabetic male patient with pain and swelling of the left 
forefoot but not any recent trauma. Microbiology identified streptococci. The medical history was positive for 
intravenous heroin abuse. The diagnosis of forefoot phlegm due to drug addition was confirmed. Treatment was 
realised by a combination of intravenous antibiosis and drainage. Intravenous drug addiction is a significant risk 
factor for SSTI. 
 
 
 
 
 
 
 
 
Introduction 
 
In the Western World, diabetic foot is the 
leading cause of soft tissue infections of the forefoot. 
The most common pathogens are bacteria, but 
mycotic and viral infections are also possible. SSTI of 
the forefoot ranges from superficial to deep infections 
to necrotising fasciitis. SSTI cause annually about 850 
000 hospitalizations in the US [1][2][3][4]. 
 
 
Case Report 
 
A 41-year-old male patient presented to the 
emergency department. He reported pain and swelling 
in the left forefoot but denied any recent trauma. He 
had slightly increased the peripheral temperature of 
37.6
0
 Celsius. On examination, we observed swelling 
of the forefoot with an injection mark but without 
sharply demarcated erythema (Fig. 1). He had small 
erosion on the lateral part of his Vth toe. On demand, 
he mentioned an earlier self-injection of heroin on 
both sites. There was no discharge from the wounds. 
The lymph nodes in the left groin were palpable and 
painful. Laboratory investigations revealed an 
elevated C-reactive protein of 65 mg/L (normal range 
< 5 mg/L) and an increased leukocyte count of 63 
Gpt/L. A microbial swab was positive for streptococcal 
spp. Magnetic resonance tomography excluded the 
involvement of fascia, muscles and bone. He was 
submitted to the Department of Orthopedic Surgery. 
Treatment was realised by a combination of 
intravenous cefuroxime 2 x 1.5 g for ten days and 
drainage. Healing was complete. 
Case Report 
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Figure 1: Forefoot phlegmon due to intravenous heroin use, small 
erosion on the Vth toe 
 
 
 
Discussion 
 
Intravenous drug addiction is a significant risk 
factor for SSTI. The presentation of intravenous 
heroin users to emergency departments is 
significantly above average [5][6]. Skin and soft tissue 
infections (SSTI) are the most common cause of 
hospital admission of injection drug users. Abscesses 
are the most frequent type of SSTI. Wound infections 
with rather unusual germs like Clostridium (C.) 
botulinum, C. novyi, tetanus or anthrax have been 
observed in heroin injectors, especially after 
subcutaneous or intramuscular injection of heroin 
("skin popping") [7][8][9].  
In the present case, neither abscess 
formation and nor erysipelas (cellulitis) was noted but 
a forefoot phlegmon due to streptococcal infection. 
The disease was treated with intravenous antibiosis 
with drainage. Complete healing was achieved. 
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